arrow
J

Jaroslav Klát

university hospital olomouc
H指数:23
被引数:2,246

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study

早期宫颈癌患者行前哨淋巴结活检术后的生活质量结局:来自前瞻性多中心SENTIX研究的结果

2026-08-100
PRE
Sentinel lymph node mapping in early-stage cervical cancer: Results from the SENTIX prospective multicenter study

早期宫颈癌的哨兵淋巴结显像:SENTIX前瞻性多中心研究的结果

2025-10-090
PRE
Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial

早期宫颈癌女性患者前哨淋巴结活检而不进行系统性盆腔淋巴结清扫术: SENTIX前瞻性单臂非劣效性国际试验的最终结果

2025-07-040
PRE
Sentinel Node Biopsy Using Two Concurrent Labeling Techniques (Radioactive Tracer With/Without Blue Dye vs. Indocyanin Green-ICG) in Early-Stage Endometrial Cancer Patients (TESLA-1): A Prospective Observational Study CEEGOG EX-02

早期子宫内膜癌患者应用两种并行标记技术的哨兵淋巴结活检(放射性示踪剂联合/不联合蓝染料与吲哚菁绿-ICG)(TESLA-1):一项前瞻性观察研究 CEEGOG EX-02

CANCERS
IF4.4
2025-05-090
OA
Preoperative tumour size assessment in patients with early-stage cervical cancer: Final results of the SENTIX study

早期宫颈癌患者术前肿瘤大小评估:SENTIX研究的最终结果

2025-05-010
PRE
The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas

罕见的妇科肉瘤研究: 379子宫肉瘤项目的分子和临床病理结果

2025-05-010
PRE
Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status

含体细胞或胚系BRCA和同源重组修复突变状态的铂敏感复发卵巢癌患者接受奥拉帕利维持治疗后的总生存期

2025-03-170
OA
Symptomatic malignant ascites drainage with a patient-controlled vascular catheter: interim analysis of safety and patient-reported outcomes

症状性恶性腹水经患者自控血管导管引流:安全性与患者报告结局的期中分析

2025-02-190
PRE
Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series
2025-01-210
OAAI
Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study

早期宫颈癌单纯手术治疗中使用前哨淋巴结和淋巴结清扫术的生存率: 宫颈癌监测 (SCCAN) 合作研究的子分析

2024-11-010
OAAI
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study

早期宫颈癌患者根治性子宫切除程度与生存率的相关性: 宫颈癌监测 (SCCAN) 合作研究的子分析

2023-10-017
PRE
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy
2022-11-304
OA
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial

基于树突状细胞的免疫疗法DCVAC/OvCa联合一线化疗 (卡铂加紫杉醇) 治疗上皮性卵巢癌的安全性和有效性: 2期,开放标签,多中心,随机试验

2022-01-0625
OAAI
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer

用于宫颈癌患者定制监测策略的年度复发风险模型

2021-11-0129
OAAI
Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study
2021-01-0145
OAAI